4//SEC Filing
GUIFFRE CHRISTOPHERD T 4
Accession 0001062993-21-012391
CIK 0001835567other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:24 PM ET
Size
15.7 KB
Accession
0001062993-21-012391
Insider Transaction Report
Form 4
GUIFFRE CHRISTOPHERD T
CFO, COO, Treas., & Asst. Sec.
Transactions
- Award
Stock Option (Right to Buy)
2021-12-03+478,533→ 478,533 totalExercise: $0.68Exp: 2027-12-13→ Common Stock (478,533 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+103,068→ 103,068 totalExercise: $1.08Exp: 2029-03-14→ Common Stock (103,068 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+51,533→ 51,533 totalExercise: $0.72Exp: 2028-03-21→ Common Stock (51,533 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+228,224→ 228,224 totalExercise: $1.29Exp: 2031-01-26→ Common Stock (228,224 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+242,948→ 242,948 totalExercise: $1.09Exp: 2030-03-24→ Common Stock (242,948 underlying)
Footnotes (10)
- [F1]25% of the shares underlying the option vested or shall vest on December 7, 2018 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter.
- [F10]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 155,000 shares of common stock of Private Pear for $1.89 per share.
- [F2]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 325,000 shares of common stock of Private Pear for $1.00 per share.
- [F3]25% of the shares underlying the option vested or shall vest on December 7, 2018 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter.
- [F4]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 35,000 shares of common stock of Private Pear for $1.05 per share.
- [F5]25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F6]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.58 per share.
- [F7]25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F8]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 165,000 shares of common stock of Private Pear for $1.60 per share.
- [F9]25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001219021
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 5:24 PM ET
- Size
- 15.7 KB